Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127496132 | 12749613 | 2 | F | 201605 | 20160907 | 20160915 | 20160920 | EXP | FR-ASTRAZENECA-2016SE95881 | ASTRAZENECA | 30.00 | YR | M | Y | 0.00000 | 20160920 | MD | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127496132 | 12749613 | 1 | PS | ARIMIDEX | ANASTROZOLE | 1 | Oral | Y | 20541 | TABLET | |||||||||
127496132 | 12749613 | 2 | SS | CLENBUTEROL | CLENBUTEROL | 1 | Unknown | Y | 0 | ||||||||||
127496132 | 12749613 | 3 | SS | ALDACTONE | SPIRONOLACTONE | 1 | Oral | Y | 0 | ||||||||||
127496132 | 12749613 | 4 | SS | TESTOSTERONE PROPIONATE. | TESTOSTERONE PROPIONATE | 1 | Intramuscular | Y | U | 0 | 1 | MG | QD | ||||||
127496132 | 12749613 | 5 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | 500 | UG | QD | |||||||||
127496132 | 12749613 | 6 | C | VENTOLINE | ALBUTEROL | 1 | 0 | ||||||||||||
127496132 | 12749613 | 7 | C | PEPTIDES | 2 | 0 | |||||||||||||
127496132 | 12749613 | 8 | C | T3/T4 THYROID HORMONES | LEVOTHYROXINELIOTHYRONINE | 1 | U | 0 | |||||||||||
127496132 | 12749613 | 9 | C | WINSTROL | STANOZOLOL | 1 | Oral | 0 | 50 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127496132 | 12749613 | 4 | Nutritional supplementation |
127496132 | 12749613 | 5 | Asthma |
127496132 | 12749613 | 6 | Asthma |
127496132 | 12749613 | 7 | Nutritional supplementation |
127496132 | 12749613 | 8 | Nutritional supplementation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127496132 | 12749613 | HO |
127496132 | 12749613 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127496132 | 12749613 | Acute kidney injury | |
127496132 | 12749613 | Electrocardiogram repolarisation abnormality | |
127496132 | 12749613 | Off label use | |
127496132 | 12749613 | Pancreatitis acute | |
127496132 | 12749613 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127496132 | 12749613 | 7 | 201605 | 0 |